Prevalence, Clinical Characteristics, and Outcomes of Sepsis Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Versus Other Pathogens in Hospitalized Patients With COVID-19-Reference-Cited by-同舟云学术

Prevalence, Clinical Characteristics, and Outcomes of Sepsis Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Versus Other Pathogens in Hospitalized Patients With COVID-19

Published:2022-05 Issue:5 Volume:4 Page:e0703
ISSN:2639-8028
Container-title:Critical Care Explorations
language:en
Short-container-title:

Author:

Shappell Claire N.,Klompas Michael,Kanjilal Sanjat,Chan Christina,Rhee Chanu

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference23 articles.

1. SARS-CoV-2 and viral sepsis: Observations and hypotheses.;Li;Lancet,2020

2. The third international consensus definitions for sepsis and septic shock (Sepsis-3).;Singer;JAMA,2016

3. Coronavirus disease 2019 as cause of viral sepsis: A systematic review and meta-analysis.;Karakike;Crit Care Med,2021

4. Does severe acute respiratory syndrome coronavirus 2 cause sepsis?;Shappell;Crit Care Med,2020

5. Prospective clinical assessments of hospitalized patients with positive SARS-CoV-2 PCR tests for necessity of isolation.;Rhee;Open Forum Infect Dis,2021

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How are Long-Covid, Post-Sepsis-Syndrome and Post-Intensive-Care-Syndrome related? A conceptional approach based on the current research literature;Critical Care;2024-08-29

2. Reduced Plasma Bone Morphogenetic Protein 6 Levels in Sepsis and Septic Shock Patients;Biomedicines;2024-07-28

3. A command centre implementation before and during the COVID-19 pandemic in a community hospital;BMC Medical Informatics and Decision Making;2024-01-08

4. Plasma Insulin-like Growth Factor-Binding Protein-2 of Critically Ill Patients Is Related to Disease Severity and Survival;Biomedicines;2023-12-12

5. Exploring the Relationship between Plasma Adiponectin, Gender, and Underlying Diseases in Severe Illness;Biomedicines;2023-12-12